Suppr超能文献

AMPK 介导高脂肪饮食诱导的肾脏疾病的发生。

AMPK mediates the initiation of kidney disease induced by a high-fat diet.

机构信息

Center for Renal Translational Medicine, Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

出版信息

J Am Soc Nephrol. 2011 Oct;22(10):1846-55. doi: 10.1681/ASN.2011010026. Epub 2011 Sep 15.

Abstract

The mechanisms underlying the association between obesity and progressive renal disease are not well understood. Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiology of kidney disease induced by a high-fat diet is unknown. In this study, we randomly assigned C57BL/6J mice to a standard or high-fat diet. After 1 week, mice fed a high-fat diet exhibited an increase in body weight, renal hypertrophy, an increase in urine H(2)O(2) and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity. Urine ACR progressively increased after 4 weeks of a high-fat diet. After 12 weeks, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed. To determine whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 week. Although AMPK activation did not abrogate the weight gain, it reduced the renal hypertrophy, urine H(2)O(2), and urine and renal MCP-1. In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells. In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.

摘要

肥胖与进行性肾脏疾病之间的关联机制尚不清楚。暴露于高脂肪饮食会降低许多器官(包括肾脏)中细胞能量传感器 AMPK 的水平,但 AMPK 是否会导致高脂肪饮食引起的肾脏疾病的病理生理学变化尚不清楚。在这项研究中,我们将 C57BL/6J 小鼠随机分配到标准饮食或高脂肪饮食组。1 周后,高脂肪饮食组的小鼠体重增加,肾脏肥大,尿液 H(2)O(2)和尿液 MCP-1 增加,循环脂联素水平和肾脏 AMPK 活性降低。高脂肪饮食 4 周后,尿 ACR 逐渐增加。12 周后,高脂肪饮食组的肾脏显示出明显的纤维化和炎症标志物增加,而 AMPK 活性仍然明显受到抑制。为了确定 AMPK 活性抑制是否解释了这些肾脏效应,我们在高脂肪饮食中同时给予 AMPK 激活剂 1 周。尽管 AMPK 激活并没有消除体重增加,但它减少了肾脏肥大、尿液 H(2)O(2)和尿液及肾脏 MCP-1。在体外,AMPK 激活完全抑制了棕榈酸诱导的系膜细胞中 MCP-1 的诱导。总之,这些数据表明,能量传感器 AMPK 介导了高脂肪饮食的早期肾脏效应。

相似文献

1
AMPK mediates the initiation of kidney disease induced by a high-fat diet.AMPK 介导高脂肪饮食诱导的肾脏疾病的发生。
J Am Soc Nephrol. 2011 Oct;22(10):1846-55. doi: 10.1681/ASN.2011010026. Epub 2011 Sep 15.

引用本文的文献

8
Kidney consequences of obesity.肥胖对肾脏的影响
Pediatr Nephrol. 2025 Jun;40(6):1879-1893. doi: 10.1007/s00467-024-06623-y. Epub 2024 Dec 16.

本文引用的文献

1
Metabolic syndrome and chronic kidney disease.代谢综合征与慢性肾脏病。
J Diabetes. 2009 Dec;1(4):236-45. doi: 10.1111/j.1753-0407.2009.00042.x. Epub 2009 Jul 8.
2
Associations of dietary fat with albuminuria and kidney dysfunction.膳食脂肪与白蛋白尿及肾功能障碍的关联。
Am J Clin Nutr. 2010 Oct;92(4):897-904. doi: 10.3945/ajcn.2010.29479. Epub 2010 Aug 11.
8
AMPK in Health and Disease.健康与疾病中的AMPK
Physiol Rev. 2009 Jul;89(3):1025-78. doi: 10.1152/physrev.00011.2008.
9
Pirfenidone is renoprotective in diabetic kidney disease.吡非尼酮对糖尿病肾病具有肾脏保护作用。
J Am Soc Nephrol. 2009 Aug;20(8):1765-75. doi: 10.1681/ASN.2008090931. Epub 2009 Jul 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验